1. Home
  2. ASRV vs RNTX Comparison

ASRV vs RNTX Comparison

Compare ASRV & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AmeriServ Financial Inc.

ASRV

AmeriServ Financial Inc.

N/A

Current Price

$4.74

Market Cap

78.4M

Sector

Finance

ML Signal

N/A

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

65.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASRV
RNTX
Founded
1983
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.4M
65.3M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
ASRV
RNTX
Price
$4.74
$0.79
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
11.6K
★ 348.7K
Earning Date
04-21-2026
05-15-2026
Dividend Yield
★ 3.16%
N/A
EPS Growth
★ 61.90
44.16
EPS
★ 0.27
N/A
Revenue
★ $14,634,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.04
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.86
$0.69
52 Week High
$5.38
$2.18

Technical Indicators

Market Signals
Indicator
ASRV
RNTX
Relative Strength Index (RSI) 50.13 50.94
Support Level $3.62 $0.71
Resistance Level $5.09 $0.85
Average True Range (ATR) 0.21 0.06
MACD -0.02 -0.00
Stochastic Oscillator 42.19 61.46

Price Performance

Historical Comparison
ASRV
RNTX

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: